THE NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESClinical Trial Agreement • April 6th, 2016 • District of Columbia
This clinical trial will be conducted through NIAID extramurally funded clinical research sites with the [select NIAID or Company or Investigator] serving as the Investigational New Drug application (IND) sponsor. However, neither the clinical research sites nor their investigators are parties to this Agreement.